Clinical Trials · NCT01869725

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

CompletedPhase 2Octreotide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Sue O'Dorisio
Enrollment
68
Start date
Apr 2013
Locations
1 site, United States
Primary endpoint
Comparison of Conventional Imaging and Gallium Ga 68-edotreotide PET Using Concordance in Tumor Detection With Pathology
View Octreotide compound reference